‘Suglat’ landed in large hospitals after ‘Forxiga’

It was observed ‘Suglat,’ a SGLT-2 inhibitor recognize as a new diabetes drug, has been settled in large hospitals, followed by the same type drug, ‘Forxiga.’

According to the observation of Medipana News on the 6^th, ‘Suglat(generic name: ipragliflozin, Astellas Pharma)’ which acquired the health insurance benefit last August has recently landed in Severance Hospital.

After getting the health...